Navigation Links
DURECT Corporation to Participate in Upcoming Healthcare Conferences
Date:11/26/2008

CUPERTINO, Calif., Nov. 26 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today that management is scheduled to present at the following upcoming healthcare conferences in New York, NY.

-- 20th Annual Piper Jaffray Health Care Conference on Wednesday, December 3rd at 8:00 a.m. Eastern Time.

-- RBC Capital Markets 2008 Healthcare Conference on Wednesday, December 10th at 12:30 p.m. Eastern Time.

A live audio webcast of the presentations will be available by accessing DURECT's homepage at http://www.durect.com and clicking "Investor Relations." If you are unable to participate during the live webcast, the call will be archived on DURECT's website under Audio Archive in the "Investor Relations" section.

About DURECT Corporation

DURECT is an emerging specialty pharmaceutical company developing innovative drugs for pain and other chronic diseases, with late-stage development programs including REMOXY(R), POSIDUR(TM), ELADUR(TM) and TRANSDUR(TM)-Sufentanil. DURECT's proprietary oral, transdermal and injectable depot delivery technologies enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs. For more information, please visit http://www.durect.com.

NOTE: POSIDUR(TM), SABER(TM), ORADUR(R), TRANSDUR(TM) and ELADUR(TM) are trademarks of DURECT Corporation. Other referenced trademarks belong to their respective owners. REMOXY, POSIDUR, ELADUR and TRANSDUR-Sufentanil are drug candidates under development and have not been approved for commercialization by the US Food and Drug Administration or other health authorities.


'/>"/>
SOURCE DURECT Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. DURECT Corporation to Participate in Upcoming Healthcare Conferences
2. DURECT Corporation Invites You to Join Its Third Quarter 2008 Earnings Conference Call
3. DURECT Announces the IND Submission for a Third Abuse-Resistant Opioid Pain Medication Based on Its ORADUR(TM) Technology
4. DURECT Corporation Invites You to Join Its Second Quarter 2008 Earnings Conference Call
5. DURECT Corporation Presenting at the 2008 UBS Global Generic and Specialty Pharmaceuticals Conference
6. DURECT Corporation Invites You to Join Its First Quarter 2008 Earnings Conference Call
7. DURECT to Participate in Morgan Stanley Global Healthcare Conference
8. DURECT Provides Update on CHRONOGESIC(R) Research Program
9. DURECT to Participate in Cowen Annual Healthcare Conference
10. DURECT to Participate in Susquehanna Financial Healthcare Conference
11. DURECT to Present at BIO CEO Investor Conference 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...wire/ -- Jon O,Brien, president of Catholics for C...ssage of HR 3962: ,, "Behavior in recent weeks... values. We in the prochoice community stayed true...gles ordinary Americans have making ends meet. The...althcare or have to choose between maintaining the...
(Date:11/8/2009)...alth holds open house at Victoria campus , ... 2009 -- UCW Academy of Health invites anyone look...health care industry to attend their open house in... Academy of Health, which offers diplomas in areas...es, designs its programs to meet the needs of the ...
(Date:11/8/2009)...quot;Preventing and Healing AIDS Through Our Inner...AIDS is a result of multiple, repeated and chronic...stressor agents, which can be either chemical, phy... Oakland, CA (PRWEB) Novem...iologists, physicians, chemists and other scientis...
(Date:11/8/2009)...wire/ -- Today, the House of Representatives passe...lsworth and Lipinski amendment to the "Affordable ...dment maintains the current policy of preventing f...ges that include abortion. It clarifies that indiv...ts and those who do not, can with their own funds ...
(Date:11/8/2009)... to Secure the Stability of Medicare ,, HOUSTO...ributable to: J. James Rohack, M.D., President, Am...www.newscom.com/cgi-bin/prnh/20081209/AMALOGO ) ...th reform bill, which will help improve the health...swift passage of H.R. 3961 to secure the stability...
Breaking Medicine News(10 mins):Health News:Catholics for Choice Statement on Healthcare Reform Bill 2Health News:College Invites Public to Explore Career Options in Health Care 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2
...H, Va., May 1, 2009 AMERIGROUP Corporation (NYSE:...cast its 2009 Annual Meeting of Stockholders on Ma...in on Thursday, May 7, 2009 at 10:00 a.m. Eastern ...amerigroupcorp.com . For those unable to listen ...
...nald McDonald House Acknowledges Decades of Servic...ore than necessary to keep the non-profit segment ...Ronald McDonald House of Delaware is making sure t...ation by LouLou,s Whimsicals. , , Muralist and in...
...tion honors journalists for orthopaedic-related co...Academy of Orthopaedic Surgeons (AAOS) has annou...n. This is the program,s fourth year and honors m...muscles and tendons. This distinguished group of ...
...recording artist joins thousands this Sunday, May ...or research fundraising events , , WASHINGTON, M...nds more will lend theirs to his as American Idol...lliers National Race for Hope, this Sunday, May 3,...
...o Broaden the Product Offering of Avalign Technolo...le Healthcare Partners ("RoundTable"), an operatin... on the healthcare industry, announced today that ...OEM medical device industry, has completed the acq...
...esources Available , , WASHINGTON, May 1 As H1N1...ean is one of the most important ways to prevent ...obably the single most effective and simplest inte...fluenza A viruses, of which swine flu is one, are ...
Other Medicine News:Health News:Artist Contributes to Volunteer Recognition 2Health News:American Academy of Orthopaedic Surgeons Announces Media Orthopaedic Reporting Excellence (MORE) Award Winners 2Health News:American Academy of Orthopaedic Surgeons Announces Media Orthopaedic Reporting Excellence (MORE) Award Winners 3Health News:American Idol David Cook Headlines National Race for Hope 2Health News:RoundTable Healthcare Partners Completes Portfolio Company Add-On Acquisition 2Health News:RoundTable Healthcare Partners Completes Portfolio Company Add-On Acquisition 3Health News:American Society for Microbiology Emphasizes Hand Hygiene as Flu Protective Measure 2
(Date:11/7/2009).... 7 Most patients with hereditary ...al an oncoming HAE attack giving the patients suff... morbidity associated with that attack, according ...rican College of Allergy, Asthma & Immunology ...oms such as fatigue and nausea, which occur freque...
(Date:11/6/2009)...TON, Pa., Nov. 6 In consultation w...cNeil Consumer Healthcare, Division of McNEIL-PPC,...ed number of product lots of TYLENOL® Arthrit...tive red EZ-OPEN CAP. McNeil is initiating the rec... taste associated with these lots that led to a sm...
(Date:11/6/2009)...6 Kaiser Foundation Health Plan, I...ir subsidiaries reported today a combined total op...nded September 30, 2009, compared to $10.2 billion...me in the third quarter was $336 million, compared.... Net non-operating income was $233 million in the...
Breaking Medicine Technology:Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 2Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 3McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 2Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 3Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 4Cold Flu or Pneumonia 3F Answer May Lie in Blood Test 53866 1Cold Flu or Pneumonia 3F Answer May Lie in Blood Test 53866 2Patient Safety Technologies Reports Second Quarter Results 53863 1Patient Safety Technologies Reports Second Quarter Results 53863 2Patient Safety Technologies Reports Second Quarter Results 53863 3Patient Safety Technologies Reports Second Quarter Results 53863 4Patient Safety Technologies Reports Second Quarter Results 53863 5Patient Safety Technologies Reports Second Quarter Results 53863 6Patient Safety Technologies Reports Second Quarter Results 53863 7ViroPharma Announces Initiation Of Non Toxigenic Clostridium Difficile Phase 1 Program 53861 1ViroPharma Announces Initiation Of Non Toxigenic Clostridium Difficile Phase 1 Program 53861 2ViroPharma Announces Initiation Of Non Toxigenic Clostridium Difficile Phase 1 Program 53861 3ViroPharma Announces Initiation Of Non Toxigenic Clostridium Difficile Phase 1 Program 53861 4
...ences(R), a business segment within SAFC(R), a mem...today announced the introduction of EX-CELL(TM) E...gned exclusively to support Vivalis, (NYSE Eurone...l production of prophylactic and therapeutic vacci...rther enable EB66 licensees in the development of ...
...on Online Activity and Podcast for Nurses and Phar...oblastic leukemia (ALL) is a complex heterogeneous...e treatment of pediatric patients, is often fatal ...nals who treat adult patients with ALL to maintain...actors affecting management options for this chall...
Other Medicine Technology:SAFC Biosciences(R) and Vivalis Collaborate to Optimize Cell Culture Media for Vaccines Production 2SAFC Biosciences(R) and Vivalis Collaborate to Optimize Cell Culture Media for Vaccines Production 3SAFC Biosciences(R) and Vivalis Collaborate to Optimize Cell Culture Media for Vaccines Production 4SAFC Biosciences(R) and Vivalis Collaborate to Optimize Cell Culture Media for Vaccines Production 5Expert Insights in Acute Lymphoblastic Leukemia: Current Challenges and Future Directions 2
The OK E-System "Compression Ortho-K"
...contact lenses used for corneal refractive therapy...ess (myopia). The patient wears the lenses overnig...During the day, nearsightedness is corrected or gr...act lenses apply slight pressure to the center of ...
Modular Cardiac Cath Labs
...maintains a large number of mobile, modular and tr...leet. The labs are typically leased to hospitals f...easing Company allows hospitals to quickly add cap...ent, initiating a new service and undergoing seaso...
Medicine Products: